ABT

Abbott Laboratories

NYSEUSDEQUITY DELAYED

116.55

▲ 2.41 (2.11%)

MARKET · —

Price

Open

114.14

Prev close

114.14

Day high

116.66

Day low

113.45

Volume

9.83M

Market cap

—

P/E (TTM)

—

52W range

81.97 – 137.49

Trailing performance

Price return · vs SPY

Returnvs SPY

+4.84% +6.2%

+15.77% +12.0%

+32.89% +29.8%

+3.95% -7.1%

YTD

-6.90% -19.2%

-11.93% -31.9%

+11.59% -62.6%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

112.00

+4.06% from price

SMA 20

109.26

+6.76% from price

SMA 50

99.94

+16.71% from price

SMA 100

95.85

+21.60% from price

SMA 200

107.08

+8.93% from price

EMA 12

111.55

+4.48% from price

EMA 26

107.37

+8.55% from price

EMA 50

102.92

+13.25% from price

RSI (14)

77.8

Overbought

MACD (12,26,9)

4.18

Hist 0.27

ATR (14)

2.35

2.01% of price

Realised vol 30D

36.2%

Annualised

Bollinger upper

115.88

20, 2σ

Bollinger lower

102.64

20, 2σ

50 / 200 cross

Death

99.94 vs 107.08

Trend bias

Above 200

+8.93%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.04

Less volatile than market

Correlation to SPY

0.02

Largely independent

Realised vol 30D

36.2%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-39.6%

Peak to trough

Max drawdown 5Y

-41.6%

Peak to trough

ATR 14

2.35

2.01% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 116.55

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

ABT · links out to the publisher

Sentinel Net Lease Announces Final Closing of Sentinel Opportunity Fund I ACCESS Newswire · 19h ago Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation Benzinga · 20h ago TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating MT Newswires · 23h ago Can Abbott Laboratories (ABT)’s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge? Insider Monkey · 1d ago Abbott Reaches $670 Million Settlement Over Infant Formula Claims MT Newswires · 1d ago Abbott to Pay $670 Million to Settle Baby-Formula Litigation The Wall Street Journal · 1d ago Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants PR Newswire · 2d ago Sector Update: Healthcare Stocks Fall Thursday Afternoon MT Newswires · 2d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.